Both in Pharmaceuticals
SELLAS Life Sciences Group vs Nurix Therapeutics
Over the past year SLS returned +482.1% and NRIX returned +140.0%; their daily moves had a correlation of 0.25.
SLS +482.1% NRIX +140.0%Growth of $1, one year, split-adjusted
| Metric | SLS | NRIX |
|---|---|---|
| Price | $11.35 | $25.51 |
| Market cap | $2.29B | $2.79B |
| Today | −6.51% | −1.96% |
| 1 month | −1.5% | +6.8% |
| 6 months | +144.6% | +54.0% |
| Year to date | +201.1% | +34.5% |
| 1 year | +494.2% | +144.8% |
| Revenue growth (YoY) | — | +8426.3% |
| Gross margin | — | 100.0% |
| Net margin | — | 81.7% |
| P/E (TTM) | — | 9.5× |
| Price / sales | — | 4.0× |
| Net cash | $138.3M | $1.05B |
| Dividend yield | — | — |
| Volatility (60d) | 91.2% | 37.0% |
| Short % of float | 27.7% | 18.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).